Cancer Home > Fludarabine Phosphate Medication Information

Fludarabine phosphate (Fludara®) is a prescription drug specifically approved for treating B-cell chronic lymphocytic leukemia, a type of cancer that affects the blood and bone marrow. The medicine comes as a daily injection that given intravenously (by IV) for 5 days in a row, every 28 days. Most people who use this product will experience some type of side effect, such as weakness, coughing, and infections.
Not everyone can use this medication. Information on fludarabine phosphate should be discussed with your healthcare provider before starting treatment to minimize your risk for certain complications. For instance, people who have problems with their kidneys or an upcoming surgery may not be able to safely use this medicine.
(Click Fludarabine for more information on this medication, including how it works, in-depth dosing guidelines, and what to do if you miss a dose.)
Written by/reviewed by:
Last reviewed by: Arthur Schoenstadt, MD
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation




Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.